|
|
Blood, 1 April 2006, Vol. 107, No. 7, pp. 2976-2983.
Prepublished online as a Blood First Edition Paper on November 29, 2005; DOI 10.1182/blood-2005-06-2562.
Previous Article | Next Article 
Submitted June 29, 2005
Accepted November 16, 2005
A novel murine model of fetal and neonatal alloimmune thrombocytopenia:Response to intravenous IgG therapy
Heyu Ni*, Pingguo Chen, Christopher M Spring, Ebrahim Sayeh, John W Semple, Alan H Lazarus, Richard O Hynes, and John Freedman
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Canadian Blood Services, Canada; The Toronto Platelet Immunobiology Group, St. Michael's Hospital, Toronto, Ontario, Canada
Canadian Blood Services, Canada; The Toronto Platelet Immunobiology Group, St. Michael's Hospital, Toronto, Ontario, Canada
The Toronto Platelet Immunobiology Group, St. Michael's Hospital, Toronto, Ontario, Canada
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; The Toronto Platelet Immunobiology Group, St. Michael's Hospital, Toronto, Ontario, Canada; Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada
Howard Hughes Medical Institute and Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; The Toronto Platelet Immunobiology Group, St. Michael's Hospital, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada
* Corresponding author; email: nih{at}smh.toronto.on.ca.
Fetal and neonatal alloimmune thrombocytopenia (FNAITP) is a life-threatening bleeding disorder caused by maternal antibodies directed against fetal platelet antigens. The immunoreactive epitopes in FNAITP are primarily located in the extracellular regions of the platelet glycoprotein IIIa ( 3 integrin). Here we have established a novel animal model of FNAITP using 3 integrin-deficient ( 3-/-) mice. We demonstrated first that these mice are immunoresponsive to 3 integrin; 3-/- mice transfused with wild-type platelets generated specific anti- 3 antibodies which were able to induce thrombocytopenia in wild-type mice. Subsequently 3-/- female mice (both naive and immunized) were bred with wild-type male mice to recapitulate the features of FNAITP. The titer of generated maternal antibodies correlated with the severity of FNAITP. High titer maternal anti- 3 antibodies caused severe fetal thrombocytopenia, intracranial hemorrhage, and even miscarriage. Furthermore, maternal administration of intravenous IgG ameliorated FNAITP and downregulated pathogenic antibodies in both the maternal and fetal circulations.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Nishie, D. Sawamura, K. Natsuga, S. Shinkuma, M. Goto, A. Shibaki, H. Ujiie, E. Olasz, K. B. Yancey, and H. Shimizu
A Novel Humanized Neonatal Autoimmune Blistering Skin Disease Model Induced by Maternally Transferred Antibodies
J. Immunol.,
September 15, 2009;
183(6):
4088 - 4093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Reheman, H. Yang, G. Zhu, W. Jin, F. He, C. M. Spring, X. Bai, P. L. Gross, J. Freedman, and H. Ni
Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor
Blood,
February 19, 2009;
113(8):
1809 - 1817.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|